Medifast, Inc. (MED) Reaches $93.45 52-Week High; Hersha Hospitality Trust (HT) Had 4 Bulls

Medifast, Inc. (NYSE:MED) Logo

The stock of Medifast, Inc. (NYSE:MED) hit a new 52-week high and has $96.25 target or 3.00% above today’s $93.45 share price. The 7 months bullish chart indicates low risk for the $1.13 billion company. The 1-year high was reported on Mar, 31 by Barchart.com. If the $96.25 price target is reached, the company will be worth $33.75M more. The stock increased 2.09% or $1.91 during the last trading session, reaching $93.45. About 232,909 shares traded or 61.18% up from the average. Medifast, Inc. (NYSE:MED) has risen 107.05% since March 31, 2017 and is uptrending. It has outperformed by 95.50% the S&P500.

Among 12 analysts covering Hersha Hospitality Trust (NYSE:HT), 4 have Buy rating, 2 Sell and 6 Hold. Therefore 33% are positive. Hersha Hospitality Trust had 40 analyst reports since July 30, 2015 according to SRatingsIntel. Robert W. Baird maintained Hersha Hospitality Trust (NYSE:HT) on Monday, October 30 with “Buy” rating. The stock of Hersha Hospitality Trust (NYSE:HT) has “Buy” rating given on Tuesday, February 27 by Robert W. Baird. The stock of Hersha Hospitality Trust (NYSE:HT) earned “Hold” rating by Stifel Nicolaus on Monday, July 17. The company was maintained on Monday, August 28 by FBR Capital. The firm has “Mkt Perform” rating given on Monday, May 1 by JMP Securities. On Friday, July 29 the stock rating was maintained by FBR Capital with “Outperform”. On Tuesday, March 29 the stock rating was reinitiated by Stifel Nicolaus with “Hold”. The firm has “Hold” rating by Stifel Nicolaus given on Thursday, December 17. FBR Capital maintained Hersha Hospitality Trust (NYSE:HT) on Wednesday, February 21 with “Buy” rating. Stifel Nicolaus maintained the stock with “Hold” rating in Tuesday, October 10 report. See Hersha Hospitality Trust (NYSE:HT) latest ratings:

27/02/2018 Broker: Robert W. Baird Rating: Buy New Target: $18.0 Maintain
21/02/2018 Broker: FBR Capital Rating: Buy New Target: $20.0 Maintain
22/02/2018 Broker: Stifel Nicolaus Old Rating: Hold New Rating: Hold Old Target: $18.5 New Target: $18 Maintain
12/02/2018 Broker: Stifel Nicolaus Rating: Hold New Target: $18.5 Maintain
13/12/2017 Broker: Barclays Capital Old Rating: Equal-Weight New Rating: Underweight Downgrade
30/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $19.0 Maintain
27/10/2017 Broker: Wells Fargo Rating: Market Perform Old Target: $18 New Target: $17 Maintain
10/10/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $19.0 Maintain

Hersha Hospitality Trust, a real estate investment trust, engages in the ownership and operation of mid scale limited service hotels in the Eastern United States. The company has market cap of $770.55 million. As of June 30, 2005, it owned interests in 35 hotels, including 4 hotels owned through joint ventures in Pennsylvania, New York, New Jersey, Maryland, Georgia, Connecticut, and Massachusetts. It has a 10 P/E ratio. The firm has elected to be taxed as a REIT under the Internal Revenue Code.

The stock decreased 0.06% or $0.01 during the last trading session, reaching $17.9. About 548,325 shares traded. Hersha Hospitality Trust (NYSE:HT) has declined 7.31% since March 31, 2017 and is downtrending. It has underperformed by 18.86% the S&P500.

Among 3 analysts covering Medifast (NYSE:MED), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Medifast has $74 highest and $32 lowest target. $53’s average target is -43.29% below currents $93.45 stock price. Medifast had 7 analyst reports since August 10, 2015 according to SRatingsIntel. The stock of Medifast, Inc. (NYSE:MED) earned “Hold” rating by Zacks on Monday, August 10. Sidoti upgraded the stock to “Buy” rating in Monday, October 5 report. The stock has “Neutral” rating by Sidoti on Monday, November 30. The firm earned “Buy” rating on Friday, September 15 by DA Davidson. DA Davidson initiated Medifast, Inc. (NYSE:MED) rating on Wednesday, August 16. DA Davidson has “Buy” rating and $65.0 target. On Monday, January 11 the stock rating was upgraded by Sidoti to “Buy”. The company was initiated on Friday, January 29 by Wunderlich.

Since March 8, 2018, it had 0 insider buys, and 3 sales for $4.87 million activity. 8,000 Medifast, Inc. (NYSE:MED) shares with value of $727,600 were sold by CONNOLLY CHARLES P. MACDONALD MICHAEL C had sold 40,000 shares worth $3.47M on Thursday, March 8.

Investors sentiment increased to 1.33 in Q4 2017. Its up 0.33, from 1 in 2017Q3. It increased, as 14 investors sold Medifast, Inc. shares while 56 reduced holdings. 36 funds opened positions while 57 raised stakes. 10.23 million shares or 0.32% more from 10.20 million shares in 2017Q3 were reported. Royal Bancshares Of Canada has 12,356 shares for 0% of their portfolio. Brown Brothers Harriman And holds 0% or 19 shares. Kennedy Capital Management Inc, a Missouri-based fund reported 69,755 shares. Panagora Asset Management has invested 0% in Medifast, Inc. (NYSE:MED). X Management Ltd holds 162 shares. James Investment Rech reported 26,290 shares or 0.06% of all its holdings. Dimensional Fund L P invested in 0.02% or 694,623 shares. Northern Tru Corporation holds 0% of its portfolio in Medifast, Inc. (NYSE:MED) for 136,883 shares. Toth Financial Advisory owns 0.01% invested in Medifast, Inc. (NYSE:MED) for 840 shares. Swiss Savings Bank stated it has 16,600 shares or 0% of all its holdings. The Kentucky-based Hl Fincl Services Ltd has invested 0.09% in Medifast, Inc. (NYSE:MED). National Bank Of America Corporation De owns 0% invested in Medifast, Inc. (NYSE:MED) for 31,334 shares. Martingale Asset Ltd Partnership invested in 0.05% or 50,706 shares. American Century Incorporated stated it has 0.02% of its portfolio in Medifast, Inc. (NYSE:MED). Jpmorgan Chase Com accumulated 152,468 shares.

Analysts await Medifast, Inc. (NYSE:MED) to report earnings on May, 3. They expect $0.86 earnings per share, up 68.63% or $0.35 from last year’s $0.51 per share. MED’s profit will be $10.35 million for 27.17 P/E if the $0.86 EPS becomes a reality. After $0.60 actual earnings per share reported by Medifast, Inc. for the previous quarter, Wall Street now forecasts 43.33% EPS growth.

Medifast, Inc., through its subsidiaries, produces, distributes, and sells weight loss, weight management, healthy living products, and other consumable health and diet products. The company has market cap of $1.13 billion. The firm offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, eggs, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape For Life, Flavors of Home, and Essential 1 brands, as well as Dual Fuel, a sports nutrition pilot program. It has a 40.81 P/E ratio. It also provides meal replacements comprising vitamins and minerals; and hydration products, as well as other nutrients for health purposes.

Medifast, Inc. (NYSE:MED) Institutional Positions Chart